Immunome (IMNM) FCF Margin (2023 - 2025)
Immunome (IMNM) reported FCF Margin of 1247.72% for Q2 2025, down 29726.0% on a YoY basis from N/an in Q2 2024, and up 31.95% quarter-over-quarter from 1833.46% in Q1 2025.
Immunome (IMNM) FCF Margin (2023 - 2025) Analysis & Trends
Immunome has reported FCF Margin for 3 years, with the latest figure at 1247.72% in Q2 2025.
- For the quarter ending Q2 2025, FCF Margin fell 29726.0% year-over-year to 1247.72%; the trailing twelve-month figure through Mar 2026 stood at 4932.68% (down 352554.0% YoY), and the FY2025 full-year result was 2765.09%, down 150859.0% from the prior year.
- FCF Margin for Q2 2025 stood at 1247.72%, up from 1833.46% in the prior quarter.
- The five-year high for FCF Margin was 1018.06% in Q1 2023, with the low at 1833.46% in Q1 2025.
- Historically, FCF Margin has averaged 792.75% across 3 years, with a median of 1050.35% in 2024.
- Annual changes were most pronounced in 2024 — FCF Margin slumped 231388 bps — and 2025, when it plunged 29726 bps.
- Immunome's FCF Margin stood at 465.45% in 2023, then sank by 248 bps to 1618.88% in 2024, then gained by 23 bps to 1247.72% in 2025.
- The last three FCF Margin figures came in at 1247.72% (Q2 2025), 1833.46% (Q1 2025), and 1618.88% (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -3.98% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 43.35% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Immunome | 2.12 Bn | 1.54 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -1,247.72% |
| Mar 31, 2025 | -1,833.46% |
| Dec 31, 2024 | -1,618.88% |
| Sep 30, 2024 | -1,150.24% |
| Jun 30, 2024 | -950.47% |
| Mar 31, 2024 | -1,295.82% |
| Dec 31, 2023 | -465.45% |
| Sep 30, 2023 | -242.64% |
| Jun 30, 2023 | -140.93% |
| Mar 31, 2023 | 1,018.06% |